MedPath

Comparison of effects and safety between peginterferon alfa-2a and peginterferon alfa-2b in simepurevir therapy for chronic hepatitis C.

Not Applicable
Conditions
Chronic hepatitis
Registration Number
JPRN-UMIN000013302
Lead Sponsor
Oita hepatitis C study
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

there is no problem about randomaization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SVR ratio
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath